Literature DB >> 19629537

Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients.

Camilla Zimmermann1, Debika Burman, Shazeen Bandukwala, Dori Seccareccia, Ebru Kaya, John Bryson, Gary Rodin, Christopher Lo.   

Abstract

INTRODUCTION: Performance status (PS) scales are used widely in oncology practice and research. We compared inter-rater agreement, between nurses and physicians, for three commonly used PS scales.
MATERIALS AND METHODS: Patients attending an oncology palliative care clinic were assessed by a physician and nurse who blindly completed Eastern Cooperative Oncology Group (ECOG), Karnofsky PS (KPS), and palliative PS (PPS) scales. Patients completed the Edmonton symptom assessment system (ESAS).
RESULTS: Inter-rater agreement (weighted kappa) for the 457 patients was 0.67 for the ECOG, 0.74 for the KPS, and 0.72 for the PPS. There was no difference between proportions of physicians' vs. nurses' ratings of KPS, >60 vs. <or=60 (McNemar's test, p = 0.33); however, physicians were more likely to rate patients as having better PS for the ECOG (77% in the 0-2 range vs. 70% for nurses, p = 0.0003) and PPS (63% in the 70-100 range vs. 54% for nurses, p = 0.0001). Physician and nurse scores of ECOG, KPS, and PPS were all correlated with ESAS distress score (Pearson correlation, r = 0.4-0.5).
CONCLUSIONS: Although inter-rater agreement was good for all three scales, physicians tended to rate patients as healthier for the PPS and ECOG. The KPS may provide greater consistency of PS ratings by different oncology professionals in clinical and research settings.

Entities:  

Mesh:

Year:  2009        PMID: 19629537     DOI: 10.1007/s00520-009-0700-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  44 in total

1.  Palliative performance scale (PPS): a new tool.

Authors:  F Anderson; G M Downing; J Hill; L Casorso; N Lerch
Journal:  J Palliat Care       Date:  1996       Impact factor: 2.250

2.  Performance status assessment in cancer patients.

Authors:  C Conill; E Verger; M Salamero
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

3.  Is the palliative performance scale a useful predictor of mortality in a heterogeneous hospice population?

Authors:  Joan Harrold; Elizabeth Rickerson; Janet T Carroll; Jennifer McGrath; Knashawn Morales; Jennifer Kapo; David Casarett
Journal:  J Palliat Med       Date:  2005-06       Impact factor: 2.947

Review 4.  Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital.

Authors:  Camilla Zimmermann; Dori Seccareccia; Allyson Clarke; David Warr; Gary Rodin
Journal:  Support Care Cancer       Date:  2006-06-27       Impact factor: 3.603

5.  Use of Palliative Performance Scale in end-of-life prognostication.

Authors:  Francis Lau; G Michael Downing; Mary Lesperance; Jack Shaw; Craig Kuziemsky
Journal:  J Palliat Med       Date:  2006-10       Impact factor: 2.947

Review 6.  Quality of life in palliative care: principles and practice.

Authors:  Stein Kaasa; Jon Håvard Loge
Journal:  Palliat Med       Date:  2003-01       Impact factor: 4.762

7.  Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.

Authors:  Abby B Siegel; Emil I Cohen; Allyson Ocean; Deborah Lehrer; Alec Goldenberg; Jennifer J Knox; Helen Chen; Sean Clark-Garvey; Alan Weinberg; John Mandeli; Paul Christos; Madhu Mazumdar; Elizabeta Popa; Robert S Brown; Shahin Rafii; Jonathan D Schwartz
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

8.  A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC).

Authors:  Samir H Patel; Munther Ajlouni; Robert Chapman; Mei Lu; Benjamin Movsas; Jae Ho Kim
Journal:  J Thorac Oncol       Date:  2007-09       Impact factor: 15.609

9.  The terrible choice: re-evaluating hospice eligibility criteria for cancer.

Authors:  David J Casarett; Jessica M Fishman; Hien L Lu; Peter J O'Dwyer; Frances K Barg; Mary D Naylor; David A Asch
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

10.  High levels of untreated distress and fatigue in cancer patients.

Authors:  L E Carlson; M Angen; J Cullum; E Goodey; J Koopmans; L Lamont; J H MacRae; M Martin; G Pelletier; J Robinson; J S A Simpson; M Speca; L Tillotson; B D Bultz
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

View more
  27 in total

1.  Development and cross-validation of the in-hospital mortality prediction in advanced cancer patients score: a preliminary study.

Authors:  David Hui; Kelly Kilgore; Bryan Fellman; Diana Urbauer; Stacy Hall; Julieta Fajardo; Wadih Rhondali; Jung Hun Kang; Egidio Del Fabbro; Donna Zhukovsky; Eduardo Bruera
Journal:  J Palliat Med       Date:  2012-06-04       Impact factor: 2.947

Review 2.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

3.  Early versus Delayed Therapy of Advanced Gastric Cancer Patients--Does It Make a Difference?

Authors:  Elena Elimova; Hironori Shiozaki; Rebecca S Slack; Hsiang-Chun Chen; Roopma Wadhwa; Kazuki Sudo; Nikolaos Charalampakis; Adarsh Hiremath; Jeannelyn S Estrella; Aurelio Matamoros; Tara Sagebiel; Prajnan Das; Jane E Rogers; Jeana L Garris; Mariela A Blum; Brian Badgwell; Jaffer A Ajani
Journal:  Oncology       Date:  2015-07-08       Impact factor: 2.935

4.  Symptom burden in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians.

Authors:  Karin Oechsle; Kathrin Goerth; Carsten Bokemeyer; Anja Mehnert
Journal:  Support Care Cancer       Date:  2013-02-21       Impact factor: 3.603

5.  Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.

Authors:  David Hui; Omar Shamieh; Carlos Eduardo Paiva; Odai Khamash; Pedro Emilio Perez-Cruz; Jung Hye Kwon; Mary Ann Muckaden; Minjeong Park; Joseph Arthur; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2015-10-19       Impact factor: 3.612

Review 6.  Improving patient and caregiver outcomes in oncology: Team-based, timely, and targeted palliative care.

Authors:  David Hui; Breffni L Hannon; Camilla Zimmermann; Eduardo Bruera
Journal:  CA Cancer J Clin       Date:  2018-09-13       Impact factor: 508.702

7.  How far along the disease trajectory? An examination of the time-related patient characteristics in the palliative oncology literature.

Authors:  Supakarn Tayjasanant; Eduardo Bruera; David Hui
Journal:  Support Care Cancer       Date:  2016-04-29       Impact factor: 3.603

8.  Factors Associated With Attrition in a Multicenter Longitudinal Observational Study of Patients With Advanced Cancer.

Authors:  Pedro E Perez-Cruz; Omar Shamieh; Carlos Eduardo Paiva; Jung Hye Kwon; Mary Ann Muckaden; Eduardo Bruera; David Hui
Journal:  J Pain Symptom Manage       Date:  2017-11-16       Impact factor: 3.612

9.  Patient Functional Status at Transplant and Its Impact on Posttransplant Survival of Adult Deceased-donor Kidney Recipients.

Authors:  Kevin Bui; Vikram Kilambi; James R Rodrigue; Sanjay Mehrotra
Journal:  Transplantation       Date:  2019-05       Impact factor: 4.939

10.  The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer.

Authors:  Breffni Hannon; Nadia Swami; Ashley Pope; Gary Rodin; Elizabeth Dougherty; Ernie Mak; Subrata Banerjee; John Bryson; Julia Ridley; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2014-10-04       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.